Much of the Covid-19 vaccines are likely to be manufactured in India through strong and strong partners in the country’s personal sector, said Mark Suzman, executive director of the Bill and Melinda Gates Foundation.
In an interview with PTI, Suzman noted that India is doing all it can right now with the resources available to combat the Covid-19 pandemic.
“I think India is doing everything in its power right now with the resources available, but we all hope that next year some of those vaccines will come out. . . “and we are waiting for a very giant component of these vaccines to be manufactured in India through strong and physically powerful components in the Indian personal sector, and this will be the key domain to focus on in the next phase of the Covid pandemic,” he said.
He wants a fair global distribution of Covid-19 vaccines.
“We passionately believe that there will have to be a fair global distribution, so all we do is make sure that the next countries can access it at the same time and in the same volumes as rich countries, because for a global pandemic it is essential, yet then the precise speed and distribution in countries will have national rules with some of the global recommendations” Array said.
Read also: Major life sciences companies, the Gates Foundation, are committed to expanding into Covid diagnostics, treatments and vaccines
He said the Bill and Melinda Gates Foundation runs to varying degrees to combat Covid-19.
“We have provided support, said upstream, or studies and development. We are working with this organization, the Coalition for Epidemic Preparedness Innovation, which has been a leading spouse in making an investment in potential vaccines. “We’ve developed something called a healing accelerator that has raised over $125 million to help locate remedies that will be effective against Covid,” he said.
He said the basis was also the basis of many diagnostic work. “And in this context, we are the strongest of this global effort, of which India is a part, called COVAX, which is a multilateral initiative to buy vaccines on a giant scale and then distribute them through the GAVI vaccine alliance to countries like India,” Suzman added.
Finally, we have also directly supported some express investments, with Indian partners such as Serum Institute of India and GAVI around express vaccines that are very promising to ensure that many products are manufactured in real time and even before regulatory approval for prospective distribution because we need to make sure that distribution goes to emerging countries at the same time as rich countries , don’t fall with rich countries that bought the anticipated market, which was risk,” he said.
He said that the greatest learning of the pandemic was that at all levels, global, regional, national, there would have to be a permanent infrastructure, prepared and able to operate, which would keep the global much more future-ready. next, coming.
“Not that the pandemic is a surprise, perhaps the magnitude, speed and precise nature of the pathogen have simply not been predicted, but since Bill Gates and others have been cautious for years, it is one of the world’s top crises. “He said.
Read also: India would possibly give up plasma treatment to treat Covid
“But we know that unknown pathogens have a chance to go in and wreak havoc, so we’ll never get stuck again. We want global infrastructure, regional infrastructure and national infrastructure, to the point of network health,” he added.
Answering a question about the relevance of the Great Challenges platform to the existing pandemic situation, he said that some of the networks and teams of scientists who have joined Great Challenges are executing many facets of Covid-19.
They also provided the platform that examines similar disorders that allow clinical leadership in emerging countries, especially women, to think about what long-term disorders will be in the long term or provide and in the long term, adding even beyond Covid-19, he added. Said.
Read also: The US AstraZeneca Covid-19 vaccine assay is in the U. S. But it’s not the first time It can resume this week
Grand Challenges India created as a partnership between the Department of Biotechnology and the bill
Grand Challenges India works on one of the priorities of fitness and progression, from agriculture, nutrition, sanitation, maternal and child health to infectious diseases.
Already have an account? Connect
Start your 14-day loose trial. Register
Get full virtual playback of The Hindu BusinessLine, The Hindu, Frontline, Sportstar, Crossword, Epaper from The Hindu and The Hindu BusinessLine at A SINGLE REDUCED PRICE.
Get a diverse set of perspectives from our experts in portfolio, banking, economics, environment and more.
Access Hindu Businessline content on desktops, tablets, and mobile devices.
Discover an ad-free cleaner with faster charging times
Customize your personal tastes and get personalized advice on your interest.
No more